Market Overview:
The global chronic fatigue syndrome drug market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic fatigue syndrome, rising awareness about chronic fatigue syndrome, and technological advancements in the field of drugs for chronic fatigue syndrome. The pain relievers and NSAIDs segment is expected to dominate the global chronic fatigue syndrome drug market during the forecast period owing to its high usage for treating various symptoms associated with chronic fatigue syndrome such as pain, inflammation, and sleep disturbances. The antidepressant and antipsychotic drugs segment is projected to grow at a higher CAGR during the forecast period due to increasing awareness about these drugs as potential treatments for chronic fatigue syndrome. Geographically, North America dominates the global Chronic Fatigue Syndrome Drug Market followed by Europe due high prevalence rate of Chronic Fatigue Syndrome (CFS) cases in these regions respectively .
Product Definition:
A drug used to treat chronic fatigue syndrome is called aminotadalafil. It is a phosphodiesterase type 5 inhibitor that helps increase blood flow to the muscles. This can improve symptoms such as muscle weakness and pain.
Pain Relievers and NSAIDs:
Pain relievers and NSAIDs are drugs used to relieve pain. They are also used for the treatment of inflammatory conditions, such as arthritis, gouty arthritis, osteoarthritis and rheumatoid arthritis. The global pain relievers market is expected to grow at a significant rate over the forecast period owing to factors such as growing geriatric population base coupled with rising incidences of chronic diseases that cause severe joint pain.
Antidepressant and Antipsychotic Drugs:
Antidepressant and antipsychotic drugs are used in the treatment of chronic fatigue syndrome. The global antidepressant and antipsychotic drugs market is expected to grow at a significant rate owing to an increase in awareness about these diseases, growing patient base across the globe, rise in disposable income levels, aging population along with increasing medical infrastructure facilities.
Application Insights:
The other application segment includes online/offline stores, hospitals and clinics, and other public venues. Chronic fatigue syndrome drugs are primarily used in the hospital as pain relievers orNSAIDs for the treatment of moderate to severe cases. The retail pharmacy is expected to be the fastest-growing segment owing to increasing awareness about chronic fatigue syndrome among general population coupled with rising healthcare costs.
The hospital was estimated as largest application market for CFS drugs in 2017 due to high prevalence of patients suffering from this condition across various hospitals in different countries worldwide. According to a study published by CDC, it has been found that approximately 1% of U.S population aged between 18 and 64 years have suffered from chronic fatigue at some point during their life span which amounts approximately 2 million individuals nation wide (1). This finding is comparable with studies conducted across various developing countries worldwide where around 1% - 3% of total population has suffered from chronic Fatigue Syndrome (CFS) during any given year (2).
Regional Analysis:
North America dominated the global chronic fatigue syndrome drug market in 2017. The presence of a large number of patients suffering from this condition and increasing healthcare expenditure are some factors contributing to its growth. In addition, the high adoption rate for novel treatment options is expected to drive regional growth over the forecast period. Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to rising awareness about chronic fatigue syndrome and other associated disorders coupled with improving healthcare infrastructure in emerging countries such as China, India, South Korea & Japan.
Major players operating in this industry include Actavis plc; Allergan PLC; Anika Therapeutics Inc.; BioMarin Pharmaceutical Inc.; Central Nervous System Laboratories Ltd.; Cephalon Inc.; Eisai Co.
Growth Factors:
- Increasing prevalence of chronic fatigue syndrome (CFS) is expected to drive the growth of the CFS drug market. According to a study by Centers for Disease Control and Prevention (CDC), CFS affects approximately 1 million adults in the U.S. The number of cases is likely underreported as many people with CFS do not seek medical help or are misdiagnosed with other conditions.
- Growing awareness about chronic fatigue syndrome and its symptoms is expected to increase demand for CFS drugs. There has been an increase in research on CFS in recent years, which has helped raise awareness about this condition among both patients and healthcare professionals. This is likely to lead to increased demand for drugs that can treat CFS effectively.
- Development of new and better-tolerated drugs for treating chronic fatigue syndrome is expected to drive growth of the market over the forecast period.. Currently, there are only a few approved drugs available for treating this condition, most of which have significant side effects profile . This leaves a large unmet need for better-tolerated therapies options among patients suffering from chronic fatigue syndrome . In addition, development of novel therapies that target specific underlying causes of CFS could provide relief from its symptoms .
Scope Of The Report
Report Attributes
Report Details
Report Title
Chronic Fatigue Syndrome Drug Market Research Report
By Type
Pain Relievers and NSAIDs, Antidepressant and Antipsychotic Drugs, Antimicrobial and Immunomodulatory Drugs
By Application
Hospital, Retail Pharmacy, Other
By Companies
Pfizer, Teva, Mylan, Depomed, Mallinckrodt Pharmaceuticals, Eli Lilly, Bayer, Novartis, Sun Pharmaceutical, Astrazeneca, Lundbeck, Arbor Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Chronic Fatigue Syndrome Drug Market Report Segments:
The global Chronic Fatigue Syndrome Drug market is segmented on the basis of:
Types
Pain Relievers and NSAIDs, Antidepressant and Antipsychotic Drugs, Antimicrobial and Immunomodulatory Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Retail Pharmacy, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Teva
- Mylan
- Depomed
- Mallinckrodt Pharmaceuticals
- Eli Lilly
- Bayer
- Novartis
- Sun Pharmaceutical
- Astrazeneca
- Lundbeck
- Arbor Pharma
Highlights of The Chronic Fatigue Syndrome Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pain Relievers and NSAIDs
- Antidepressant and Antipsychotic Drugs
- Antimicrobial and Immunomodulatory Drugs
- By Application:
- Hospital
- Retail Pharmacy
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chronic Fatigue Syndrome Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chronic Fatigue Syndrome Drug is a medication used to treat Chronic Fatigue Syndrome.
Some of the major companies in the chronic fatigue syndrome drug market are Pfizer, Teva, Mylan, Depomed, Mallinckrodt Pharmaceuticals, Eli Lilly, Bayer, Novartis, Sun Pharmaceutical, Astrazeneca, Lundbeck, Arbor Pharma.
The chronic fatigue syndrome drug market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Chronic Fatigue Syndrome Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Chronic Fatigue Syndrome Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Chronic Fatigue Syndrome Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Chronic Fatigue Syndrome Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Chronic Fatigue Syndrome Drug Market Size & Forecast, 2018-2028
4.5.1 Chronic Fatigue Syndrome Drug Market Size and Y-o-Y Growth
4.5.2 Chronic Fatigue Syndrome Drug Market Absolute $ Opportunity
Chapter 5 Global Chronic Fatigue Syndrome Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Chronic Fatigue Syndrome Drug Market Size Forecast by Type
5.2.1 Pain Relievers and NSAIDs
5.2.2 Antidepressant and Antipsychotic Drugs
5.2.3 Antimicrobial and Immunomodulatory Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Chronic Fatigue Syndrome Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Chronic Fatigue Syndrome Drug Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Chronic Fatigue Syndrome Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Chronic Fatigue Syndrome Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Chronic Fatigue Syndrome Drug Analysis and Forecast
9.1 Introduction
9.2 North America Chronic Fatigue Syndrome Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Chronic Fatigue Syndrome Drug Market Size Forecast by Type
9.6.1 Pain Relievers and NSAIDs
9.6.2 Antidepressant and Antipsychotic Drugs
9.6.3 Antimicrobial and Immunomodulatory Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Chronic Fatigue Syndrome Drug Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Retail Pharmacy
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Chronic Fatigue Syndrome Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Chronic Fatigue Syndrome Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Chronic Fatigue Syndrome Drug Market Size Forecast by Type
10.6.1 Pain Relievers and NSAIDs
10.6.2 Antidepressant and Antipsychotic Drugs
10.6.3 Antimicrobial and Immunomodulatory Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Chronic Fatigue Syndrome Drug Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Retail Pharmacy
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Chronic Fatigue Syndrome Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Chronic Fatigue Syndrome Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Chronic Fatigue Syndrome Drug Market Size Forecast by Type
11.6.1 Pain Relievers and NSAIDs
11.6.2 Antidepressant and Antipsychotic Drugs
11.6.3 Antimicrobial and Immunomodulatory Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Chronic Fatigue Syndrome Drug Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Retail Pharmacy
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Chronic Fatigue Syndrome Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Chronic Fatigue Syndrome Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Chronic Fatigue Syndrome Drug Market Size Forecast by Type
12.6.1 Pain Relievers and NSAIDs
12.6.2 Antidepressant and Antipsychotic Drugs
12.6.3 Antimicrobial and Immunomodulatory Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Chronic Fatigue Syndrome Drug Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Retail Pharmacy
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Chronic Fatigue Syndrome Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Chronic Fatigue Syndrome Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Chronic Fatigue Syndrome Drug Market Size Forecast by Type
13.6.1 Pain Relievers and NSAIDs
13.6.2 Antidepressant and Antipsychotic Drugs
13.6.3 Antimicrobial and Immunomodulatory Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Chronic Fatigue Syndrome Drug Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Retail Pharmacy
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Chronic Fatigue Syndrome Drug Market: Competitive Dashboard
14.2 Global Chronic Fatigue Syndrome Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Teva
14.3.3 Mylan
14.3.4 Depomed
14.3.5 Mallinckrodt Pharmaceuticals
14.3.6 Eli Lilly
14.3.7 Bayer
14.3.8 Novartis
14.3.9 Sun Pharmaceutical
14.3.10 Astrazeneca
14.3.11 Lundbeck
14.3.12 Arbor Pharma
